Latest Scorpion Stories

Brett Smith for redOrbit.com - Your Universe Online The new species Tityus (Atreus) crassicauda is described as having a reddish-brown coloration with three longitudinal brown stripes separated by yellow patches. Classified as medium sized, the scorpion averages about 2 inches in length. In the Ecuadorian winter of 2012, researchers collected scorpions from mountains within the country’s Andean region. A male and female from those collections were determined to be a new species...

Connie K. Ho for redOrbit.com – Your Universe Online A woman in Arizona was recently charged a hefty fee after treatment for a sting from a scorpion, adding scrutiny to the debate on the cost of health care in the U.S. In particular, Marcie Edmonds stated that she received a medical bill for over $83,000 from the Chandler Regional Medical Center. According to the Huffington Post, the bill included two doses of anti-venom that cost almost $40,000 for each dose. Humana, Edmonds’...

VALENCIA, Calif., April 12, 2012 /PRNewswire-iReach/ -- In early 2012, Scorpion Design, Inc. was honored with the 2012 Internet Advertising Competition Award for Best Legal Website for their work with Houston firm Arnold & Itkin on their offshore injury site. After receiving this prestigious recognition, Scorpion Design's CEO Rustin Kretz decided that it was time to push the design and technological envelope on their own website at www.scorpiondesign.com - using it to showcase...

Brett Smith for RedOrbit.com Discovery of a new giant wasp species last year has led to the discovery of an even larger species than had been sitting in a collection for 80 years. Megalara garuda hails from the Indonesian island of Sulawesi, the same island where a team led by professor Lynn Kimsey (UC Davis) discovered the wasp’s slightly smaller relative Dalara garuda. Both species belong to the digger wasp family, a diverse group of wasps that sting and paralyze prey insects....

Taking inspiration from the yellow fattail scorpion, which uses a bionic shield to protect itself against scratches from desert sandstorms, scientists have developed a new way to protect the moving parts of machinery from wear and tear. A report on the research appears in ACS' journal Langmuir. Zhiwu Han, Junqiu Zhang, Wen Li and colleagues explain that "solid particle erosion" is one of the important reasons for material damage or equipment failure. It causes millions of dollars of damage...

Gila monsters are large venomous lizards. Although envenomation by the Gila monster is not often fatal to adult humans, it results in intense pain, swelling, weakness, and nausea. A team of researchers, led by Stephen Galli, at Stanford University School of Medicine, Stanford, has now uncovered a natural mechanism by which mice reduce the toxicity, and thereby the morbidity and mortality, of Gila monster venom — immune cells known as mast cells release the protein MCPT4, which degrades the...

In the news release, Rare Disease Therapeutics, Inc. Selects Accredo Health Group to Distribute Anascorp® for the Treatment of Centruroides Scorpion Sting Envenomation, issued 13-Sep-2011 by Medco Health Solutions, Inc. over PR Newswire, we are advised by the company that the dateline cities should read "FRANKLIN and MEMPHIS, Tenn." rather than "FRANKLIN LAKES, N.J. and MEMPHIS, Tenn." as originally issued inadvertently. The complete, corrected release follows: Rare Disease...

FRANKLIN LAKES, N.J. and MEMPHIS, Tenn., Sept. 13, 2011 /PRNewswire/ -- Rare Disease Therapeutics, Inc. (RDT) announced today that its recently approved Anascorp® (Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection) is now available on the market through Accredo Health Group, Inc. - a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS). On August 3, 2011, Anascorp became the first treatment approved by the United States Food and Drug Administration (FDA) for...

The Food and Drug Administration has approved the first-ever drug as scorpion-sting antivenom. Anascorp, an antivenom produced in Mexico, was tested in U.S. clinical trials.This is the first time a drug that was fully developing in Latin American that has been approved by the FDA. "This is an historic event," Dr. Leslie Boyer, director of the University of Arizona's VIPER Institute (Venom Immunochemistry, Pharmacology and Emergency Response Institute) and lead investigator on the...

SILVER SPRING, Md., Aug. 3, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Venomous scorpions in the U.S. are mostly found in Arizona. Severe stings occur most frequently in infants and children, and can cause shortness of breath, fluid in the lungs, breathing problems, excess saliva,...